| Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ... Viruses 11 (8), 762, 2019 | 330 | 2019 |
| Effects of previous infection and vaccination on symptomatic omicron infections HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... New England Journal of Medicine 387 (1), 21-34, 2022 | 264 | 2022 |
| Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ... New England Journal of Medicine 386 (19), 1804-1816, 2022 | 255 | 2022 |
| Epstein–Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update MK Smatti, DW Al-Sadeq, NH Ali, G Pintus, H Abou-Saleh, GK Nasrallah Frontiers in oncology 8, 211, 2018 | 250 | 2018 |
| Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ... Nature communications 13 (1), 3082, 2022 | 136 | 2022 |
| Viral-induced enhanced disease illness MK Smatti, AA Al Thani, HM Yassine Frontiers in microbiology, 2991, 2018 | 134 | 2018 |
| Immune modulatory effects of vitamin D on viral infections M Siddiqui, JS Manansala, HA Abdulrahman, GK Nasrallah, MK Smatti, ... Nutrients 12 (9), 2879, 2020 | 74 | 2020 |
| Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar MK Smatti, HM Yassine, R AbuOdeh, A AlMarawani, SA Taleb, AA Althani, ... PLoS One 12 (12), e0189033, 2017 | 74 | 2017 |
| Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant AA Butt, SR Dargham, S Loka, RM Shaik, H Chemaitelly, P Tang, ... Clinical Infectious Diseases 75 (1), e361-e367, 2022 | 68 | 2022 |
| Mixed viral-bacterial infections and their effects on gut microbiota and clinical illnesses in children S Mathew, MK Smatti, K Al Ansari, GK Nasrallah, AA Al Thani, ... Scientific reports 9 (1), 1-12, 2019 | 64 | 2019 |
| Protective effect of previous SARS-CoV-2 infection against omicron BA. 4 and BA. 5 subvariants HN Altarawneh, H Chemaitelly, HH Ayoub, MR Hasan, P Coyle, ... New England Journal of Medicine 387 (17), 1620-1622, 2022 | 56 | 2022 |
| Distinct antibody repertoires against endemic human coronaviruses in children and adults T Khan, M Rahman, F Al Ali, SSY Huang, M Ata, Q Zhang, P Bastard, ... JCI insight 6 (4), 2021 | 49* | 2021 |
| Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage H Chemaitelly, HH Ayoub, P Coyle, P Tang, HM Yassine, HA Al-Khatib, ... Nature Communications 13 (1), 4675, 2022 | 43 | 2022 |
| Viral meningitis: an overview A Kohil, S Jemmieh, MK Smatti, HM Yassine Archives of Virology 166, 335-345, 2021 | 38 | 2021 |
| Duration of immune protection of SARS-CoV-2 natural infection against reinfection H Chemaitelly, N Nagelkerke, HH Ayoub, P Coyle, P Tang, HM Yassine, ... Journal of Travel Medicine 29 (8), taac109, 2022 | 36 | 2022 |
| Host genetic variants potentially associated with SARS-CoV-2: a multi-population analysis MK Smatti, YA Al-Sarraj, O Albagha, HM Yassine Frontiers in genetics 11, 578523, 2020 | 33 | 2020 |
| Hepatitis B virus molecular epidemiology, host-virus interaction, coinfection, and laboratory diagnosis in the MENA region: An update DW Al-Sadeq, SA Taleb, RE Zaied, SM Fahad, MK Smatti, BR Rizeq, ... Pathogens 8 (2), 63, 2019 | 32 | 2019 |
| Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA. 1 and BA. 2 Omicron infections and severe COVID-19 in Qatar HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ... MedRxiv, 2022.03. 22.22272745, 2022 | 31 | 2022 |
| Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar H Chemaitelly, HH Ayoub, S AlMukdad, P Tang, MR Hasan, HM Yassine, ... medRxiv, 2022.02. 07.22270568, 2022 | 29 | 2022 |
| Use of hemagglutinin stem probes demonstrate prevalence of broadly reactive group 1 influenza antibodies in human sera HM Yassine, PM McTamney, JC Boyington, TJ Ruckwardt, MC Crank, ... Scientific reports 8 (1), 1-11, 2018 | 29 | 2018 |
HADI M. YASSINESection Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar University在 QU.edu.qa 的电子邮件经过验证
